The best indicator for Quest Diagnostics (DGX)
We backtested 366 indicators across daily, weekly and hourly charts on real Quest Diagnostics (DGX) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Williams %R
On the weekly chart, this is the strongest risk-adjusted edge we found for Quest Diagnostics (DGX) over ~29.6 years — trailing buy-and-hold by 5.9% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for Quest Diagnostics (DGX) — trailing buy-and-hold by 9.0% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Williams %R ✓ | Weekly | 9.9% | 0.68 | -34.7% | 74.4% | 43 | -5.9% |
| 2 | QQE ✓ | Weekly | 14.9% | 0.66 | -40.9% | 50.0% | 88 | -0.9% |
| 3 | CCI ✓ | Weekly | 8.4% | 0.63 | -27.5% | 78.1% | 32 | -7.4% |
| 4 | Murrey Math Lines ✓ | Weekly | 7.9% | 0.63 | -27.5% | 100.0% | 16 | -7.8% |
| 5 | Projection Bands ✓ | Weekly | 9.6% | 0.63 | -27.8% | 78.8% | 52 | -6.2% |
| 6 | Chande-Kroll Stop (fast) ✓ | Weekly | 12.4% | 0.6 | -51.3% | 51.5% | 97 | -3.3% |
| 7 | Disparity Index | Weekly | 10.6% | 0.59 | -32.1% | 41.8% | 91 | -5.1% |
| 8 | SMC: Liquidity Sweep ✓ | Weekly | 8.9% | 0.59 | -35.5% | 90.5% | 21 | -6.9% |
| 9 | Chandelier Exit ✓ | Daily | 11.3% | 0.58 | -35.7% | 41.8% | 282 | -4.8% |
| 10 | Pretty Good Oscillator | Weekly | 10.3% | 0.58 | -32.1% | 41.8% | 91 | -5.4% |
| 11 | Intraday Momentum Index ✓ | Daily | 8.3% | 0.56 | -34.4% | 73.8% | 80 | -7.8% |
| 12 | Ehlers TrendFlex ✓ | Daily | 10.3% | 0.56 | -42.9% | 52.8% | 159 | -5.8% |
| 13 | WaveTrend (8/6/4) ✓ | Weekly | 7.5% | 0.56 | -27.5% | 95.2% | 21 | -8.2% |
| 14 | Least Squares MA ✓ | Weekly | 9.7% | 0.56 | -24.7% | 54.4% | 125 | -6.1% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Quest Diagnostics (DGX), Williams %R on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.